{"text": ["Roche", "Gets", "FDA", "Nod", "for", "Venclexta", "Plus", "Gazyva", "to", "Treat", "CLL"], "created_at": "2019-05-17 21:19:09"}
{"text": ["AbbVie", "halts", "enrollment", "after", "brain", "cancer", "trial", "misses", "goal,", "shares", "fall"], "created_at": "2019-05-17 13:19:06"}
{"text": ["AbbVie", "stock", "down", "1.8%", "in", "premarket", "trade", "after", "failure", "of", "glioblastoma", "drug", "trial"], "created_at": "2019-05-17 13:00:00"}
{"text": ["AbbVie", "Provides", "Update", "on", "Depatuxizumab", "Mafodotin", "(Depatux-M),", "an", "Investigational", "Medicine", "for", "Newly", "Diagnosed", "Glioblastoma,", "an", "Aggressive", "Form", "of", "Brain", "Cancer"], "created_at": "2019-05-17 12:45:00"}
{"text": ["Pharma", "Stock", "Roundup:", "FDA", "Okays", "Line", "Extensions", "of", "LLY,", "PFE,", "ABBV", "Cancer", "Drugs"], "created_at": "2019-05-17 12:35:12"}
